Detalhe da pesquisa
1.
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.
Cell
; 185(16): 2918-2935.e29, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803260
2.
Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.
Oncologist
; 29(3): e382-e391, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874927
3.
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design.
Future Oncol
; 20(12): 739-748, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197296
4.
Diagnostic performance of computed tomography features in detecting oropharyngeal squamous cell carcinoma extranodal extension.
Eur Radiol
; 33(5): 3693-3703, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719493
5.
Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
Cancer
; 128(3): 487-496, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34665873
6.
Head and neck cancer.
Lancet
; 398(10318): 2289-2299, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562395
7.
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Oncologist
; 27(2): e194-e198, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641218
8.
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(8): 925-951, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948029
9.
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
J Natl Compr Canc Netw
; 20(3): 224-234, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276673
10.
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lancet Oncol
; 22(4): 450-462, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794205
11.
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.
Oncologist
; 25(7): 598-608, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32310325
12.
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(7): 873-898, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634781
13.
Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series.
Oral Dis
; 26(2): 325-333, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31642136
14.
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
Cancer
; 125(18): 3208-3218, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31246283
15.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
N Engl J Med
; 375(19): 1856-1867, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718784
16.
A Primary Care Ultrasound Fellowship: Training for Clinical Practice and Future Educators.
J Ultrasound Med
; 38(4): 1061-1068, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30182369
17.
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.
Br J Cancer
; 119(2): 153-159, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955135
18.
Head and neck cancer: high-end technology is no guarantee of high-quality care - Authors' reply.
Lancet
; 399(10341): 2102, 2022 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658994
19.
Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.
Oncologist
; 23(7): 814-821, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29445030
20.
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Oncologist
; 23(9): 1079-1082, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866947